Sophiris Bio, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2013. For the quarter, the company reported net loss before income tax expense was $2,952,030 compared to $5,630,000 a year ago. Net loss was $2,952,000 or $0.31 per basic and diluted share compared to $5,630,000 or $1.79 per basic and diluted share a year ago.

For nine months, the company reported revenue of $5,000,000. Net loss before income tax expense was $5,211,000 compared to $15,863,000 a year ago. Net loss was $5,711,000 or $1.08 per basic and diluted share compared to $15,863,000 or $5.25 per basic and diluted share a year ago. Net cash flows used in operating activities was of $8,822,000 compared to $15,017,000 a year ago. Purchase of property and equipment was of $3,000 compared to $26,000 a year ago.